CAPTRUST Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $186M | Buy |
202,206
+36,417
| +22% | +$36.9M | 0.32% | 63 |
|
|
2025
Q4 | $178M | Sell |
165,789
-2,563
| -2% | -$2.45M | 0.34% | 54 |
|
|
2025
Q3 | $128M | Sell |
168,352
-2,979
| -2% | -$2.22M | 0.26% | 77 |
|
|
2025
Q2 | $134M | Sell |
171,331
-2,620
| -2% | -$2.04M | 0.3% | 68 |
|
|
2025
Q1 | $144M | Sell |
173,951
-27,547
| -14% | -$22.9M | 0.36% | 52 |
|
|
2024
Q4 | $156M | Sell |
201,498
-13,041
| -6% | -$10.8M | 0.44% | 43 |
|
|
2024
Q3 | $190M | Sell |
214,539
-47,729
| -18% | -$42.9M | 0.56% | 33 |
|
|
2024
Q2 | $237M | Sell |
262,268
-336,566
| -56% | -$269M | 0.76% | 28 |
|
|
2024
Q1 | $226M | Buy |
598,834
+293,050
| +96% | +$209M | 0.83% | 23 |
|
|
2023
Q4 | $178M | Buy |
305,784
+2,574
| +0.8% | +$1.5M | 0.61% | 28 |
|
|
2023
Q3 | $163M | Buy |
303,210
+714
| +0.2% | +$368K | 0.62% | 31 |
|
|
2023
Q2 | $142M | Sell |
302,496
-67,925
| -18% | -$28.5M | 0.56% | 33 |
|
|
2023
Q1 | $127M | Sell |
370,421
-200
| -0.1% | -$67.5K | 0.56% | 35 |
|
|
2022
Q4 | $136M | Buy |
370,621
+22,554
| +6% | +$8M | 0.68% | 27 |
|
|
2022
Q3 | $113M | Sell |
348,067
-7,717
| -2% | -$2.45M | 0.66% | 30 |
|
|
2022
Q2 | $115M | Buy |
355,784
+42,016
| +13% | +$12.6M | 0.74% | 22 |
|
|
2022
Q1 | $89.9M | Buy |
313,768
+33,807
| +12% | +$8.7M | 0.58% | 30 |
|
|
2021
Q4 | $77.3M | Buy |
279,961
+11,642
| +4% | +$2.95M | 0.53% | 38 |
|
|
2021
Q3 | $62M | Buy |
268,319
+34,709
| +15% | +$8.57M | 0.52% | 42 |
|
|
2021
Q2 | $53.6M | Buy |
233,610
+157,187
| +206% | +$31.6M | 0.5% | 44 |
|
|
2021
Q1 | $14.3M | Buy |
76,423
+6,102
| +9% | +$1.19M | 0.15% | 142 |
|
|
2020
Q4 | $11.9M | Sell |
70,321
-65,734
| -48% | -$9.81M | 0.16% | 142 |
|
|
2020
Q3 | $19.6M | Buy |
136,055
+2,291
| +2% | +$355K | 0.33% | 83 |
|
|
2020
Q2 | $21.8M | Buy |
133,764
+19,897
| +17% | +$3.05M | 0.36% | 75 |
|
|
2020
Q1 | $15.5M | Buy |
113,867
+27,040
| +31% | +$3.72M | 0.34% | 77 |
|
|
2019
Q4 | $11.5M | Buy |
86,827
+63,187
| +267% | +$7.32M | 0.18% | 139 |
|
|
2019
Q3 | $2.64M | Sell |
23,640
-325
| -1% | -$36.2K | 0.09% | 188 |
|
|
2019
Q2 | $2.65M | Sell |
23,965
-1,696
| -7% | -$200K | 0.1% | 181 |
|
|
2019
Q1 | $3.33M | Buy |
25,661
+4,034
| +19% | +$491K | 0.14% | 132 |
|
|
2018
Q4 | $2.5M | Buy |
21,627
+87
| +0.4% | +$9.72K | 0.13% | 132 |
|
|
2018
Q3 | $2.31M | Buy |
21,540
+12,360
| +135% | +$1.24M | 0.1% | 135 |
|
|
2018
Q2 | $783K | Buy |
9,180
+6,784
| +283% | +$557K | 0.04% | 201 |
|
|
2018
Q1 | $181K | Sell |
2,396
-315
| -12% | -$25.4K | 0.01% | 331 |
|
|
2017
Q4 | $229K | Buy |
2,711
+2,311
| +578% | +$197K | 0.01% | 306 |
|
|
2017
Q3 | $30K | Buy |
+400
| New | +$32.8K | ﹤0.01% | 316 |
|
Other funds holding LLY
VCM
VPM
CAPTRUST Financial Advisors's LLY Position: Q1 2026 in Review
CAPTRUST Financial Advisors increased its Eli Lilly (LLY) stake by 22% in Q1 2026, buying an estimated $36.9M and bringing the position to 202,206 shares worth $186M. The position accounts for 0.32% of the portfolio, ranked #63.
CAPTRUST Financial Advisors first reported a position in LLY in Q3 2017 and has held it in 35 quarters since. The position peaked at $237M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- CAPTRUST Financial Advisors held 202,206 shares of Eli Lilly worth $186M as of Q1 2026.
- CAPTRUST Financial Advisors bought 36,417 Eli Lilly shares in Q1 2026, an estimated $36.9M.
- Eli Lilly made up 0.32% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #63 holding.
- CAPTRUST Financial Advisors first reported a position in Eli Lilly in Q3 2017 and has held it in 35 quarters since.
- CAPTRUST Financial Advisors's Eli Lilly position peaked at $237M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.